Factors affecting the curative effect of allogeneic stem cell transplantation in patients with high-risk chronic lymphocytic leukaemia

被引：0
|
作者：
Iori, A. P.
Laurenti, L.
Piciocchi, A.
Severino, A.
Chiusolo, P.
Mauro, F. R.
Torelli, G. F.
Della Starza, I.
Majolino, I.
Locasciulli, A.
Meloni, G.
Sica, S.
Leone, G.
Foa, R.
机构：
来源：
BONE MARROW TRANSPLANTATION | 2010年 / 45卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S243 / S244
页数：2
相关论文
共 50 条
  • [41] Complete donor T-cell engraftment 30 days after allogeneic transplantation predicts molecular remission in high-risk chronic lymphocytic leukaemia
    Jones, Carol D.
    Arai, Sally
    Lowsky, Robert
    Tyan, Dolly B.
    Zehnder, James L.
    Miklos, David B.
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 150 (05) : 637 - 639
  • [42] Role of allogeneic hematopoietic stem cell transplantation in patients with high-risk T-cell lymphoblastic leukaemia/lymphoma: an analysis of clinical outcomes
    Zhang, Xiaoting
    Pang, Yuyang
    Wei, Cong
    Liang, Dan
    Yang, Shaoxin
    Zhao, Chong
    Huang, Rui
    Deng, Lan
    BONE MARROW TRANSPLANTATION, 2024, 59 (03) : 422 - 424
  • [43] Risk factors analysis of haematopoietic stem cell transplantation in treatment of patients with chronic myeloid leukaemia
    Gil, L
    Zaucha, JM
    Czyz, A
    Styczynski, J
    Bieniaszewska, M
    Hellman, A
    Komarnicki, M
    BONE MARROW TRANSPLANTATION, 2006, 37 : S230 - S230
  • [44] Prognostic factors for patients with acute myeloid leukaemia or high-risk myelodysplastic syndromes undergoing myeloablative or non-myeloablative allogeneic blood stem cell transplantation
    Graef, Thorsten
    Vaupel, Matthias
    Fenk, Roland
    Ruf, Leilan
    Zohren, Fabian
    Germing, Ulrich
    Haas, Rainer
    Kobbe, Guido
    HEMATOLOGICAL ONCOLOGY, 2007, 25 (04) : 170 - 177
  • [45] Outcome of immunotherapeutic rescue strategies for clinical relapse of high-risk chronic lymphocytic leukemia (CLL) in patients after allogeneic hematopoietic stem cell transplantation (HSCT)
    Hahn, M.
    Dietrich, S.
    Herth, I.
    Hegenbart, U.
    Walter, E.
    Rieger, M.
    Stadtherr, P.
    Bondong, A.
    Ho, A. D.
    Dreger, P.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 51 - 51
  • [46] Allogeneic Stem Cell Transplantation for High/Ultra High-Risk Multiple Myeloma
    Weeks, Charles
    Vuppala, Rohan
    Gold, Matthew
    Simon, Abigayle
    Jillella, Anand
    Cortes, Jorge
    Kota, Vamsi
    JOURNAL OF HEMATOLOGY, 2025, 14 (01) : 38 - 42
  • [47] Allogeneic Stem-Cell Transplantation for Chronic Lymphocytic Leukemia
    Atilla, Erden
    Atilla, Pinar Ataca
    Pekcan, Gultekin
    Ilhan, Osman
    Gurman, Gunhan
    Ozcan, Muhit
    Arslan, Onder
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S262 - S263
  • [48] Autologous stem cell transplantation in patients with early chronic lymphocytic leukaemia: A chance for cure?
    Dreger, P
    vonNeuhoff, N
    Kuse, R
    Viehmann, K
    Zeis, M
    Mundt, T
    Suttorp, M
    Loffler, H
    Schmitz, N
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 438 - 438
  • [49] Autologous and allogeneic stem cell transplantation for chronic lymphocytic leukemia
    Dreger, P
    Montserrat, E
    LEUKEMIA, 2002, 16 (06) : 985 - 992
  • [50] Autologous and allogeneic stem cell transplantation for chronic lymphocytic leukemia
    P Dreger
    E Montserrat
    Leukemia, 2002, 16 : 985 - 992
12345